Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOKETOCONAZOLE vs LEVOLEUCOVORIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOKETOCONAZOLE vs LEVOLEUCOVORIN: Safety Overview

Metric LEVOKETOCONAZOLE LEVOLEUCOVORIN
Total FAERS Reports 309 3,168
Deaths Reported 8 421
Death Rate 2.6% 13.3%
Hospitalizations 99 1,413
Average Patient Age 54.8 yrs 64.9 yrs
% Female Patients 86.3% 36.1%
FDA Approval Date Dec 30, 2021 Apr 29, 2011
Manufacturer Xeris Pharmaceuticals, Inc. Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued